Track topics on Twitter Track topics that are important to you
InflaRx N.V., a biopharmaceutical company developing innovative therapeutics to treat life─threatening inflammatory diseases by targeting the complement system, a key component of the innate immune ...
The investigative new drug application for InflaRx's drug candidate IFX-1 was approved by the FDA, allowing the company to la -More-
Lead candidate, IFX-1 is advancing through clinical trials with Phase IIB data in hidradenitis suppurativa expected 1H19
InflaRx (Nasdaq:IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and spec...
InflaRx is a clinical-stage biopharmaceutical company focusing on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibito...
About: Affentranger Associates SA
We have published hundreds of InflaRx N.V. news stories on BioPortfolio along with dozens of InflaRx N.V. Clinical Trials and PubMed Articles about InflaRx N.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InflaRx N.V. Companies in our database. You can also find out about relevant InflaRx N.V. Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...